Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Founded in 1989, Medis Medical Imaging Systems B.V. provides high-quality quantitative analysis solutions for cardiovascular imaging to the medical community. Medis’ software is internationally appreciated due to its ease of use and clinical outcomes for patients. The company continuously focuses on creating, researching and innovating towards clinically relevant software solutions in the field of cardiovascular imaging.

Oaklins’ team in the Netherlands acted as the exclusive strategic advisor to the shareholders and management of Medis Medical Imaging Systems B.V.

Services

Conseil en financement par dette ou en équité

Parties prenantes

«We are delighted to be taking this next step with GE HealthCare, a fellow leader in the interventional cardiology domain. Building on Medis QFR’s decade of AI research, customer-focused product development, clinical evidence generation and business development, we are excited to be able to further accelerate our efforts around Medis QFR to enable more hospitals and clinicians to apply physiology in day-to-day interventional practice as part of clinical care best practices, making this technology more accessible and available to patients than ever before.»

Maya Barley

CEO, Medis Medical Imaging Systems B.V.

Contacter l'équipe de la transaction

Martijn de Win

Directeur

Amsterdam, Pays-Bas
Oaklins Netherlands

Voir le profil Entrer en contact

Robert Boersma

Associé

Amsterdam, Pays-Bas
Oaklins Netherlands

Voir le profil Entrer en contact

Robbert Bon

Analyste principal

Amsterdam, Pays-Bas
Oaklins Netherlands

Voir le profil Entrer en contact

Transactions connexes

Middlecon has been acquired by Nion

TMT

Middlecon has been acquired by Nion

Middlecon has been acquired by Nion, a digital consultancy backed by Stella Capital. The acquisition strengthens Nion’s capabilities in data management and advanced analytics, enabling it to undertake larger and more complex data-driven initiatives for its customers. The partnership with Nion provides Middlecon with a strong foundation for continued growth and expansion.

En apprendre plus

Backspin has completed a mandatory public tender offer for the shares of Spindox

Placements Privés | TMT

Backspin has completed a mandatory public tender offer for the shares of Spindox

Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.

En apprendre plus

Rare Patient Voice has been acquired by Konovo

Soins de la Santé | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

En apprendre plus